SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2018 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 28, 2018, between CEL-SCI Corporation, a Colorado corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT’S COMMON STOCK PURCHASE WARRANT SERIES WW CEL-SCI CORPORATIONSecurities Agreement • June 29th, 2018 • Cel Sci Corp • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after six (6) months following the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 28, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from CEL-SCI Corporation, a Colorado corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of June 26, 2018, by and between the Company and H.C. Wainwright & Co., LLC.
STRICTLY CONFIDENTIAL CEL-SCI CorporationExclusive Agency Agreement • June 29th, 2018 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
